These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10533617)

  • 21. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of L-749,329, an ET(A)/ET(B) endothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis.
    Huckle WR; Drag MD; Acker WR; Powers M; McFall RC; Holder DJ; Walsh TF; Schwartz RS; Greenlee WJ; Johnson RG
    Circulation; 2001 Apr; 103(14):1899-905. PubMed ID: 11294810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
    Li P; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1065-70. PubMed ID: 9190837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Aoki M; Sakonjo H; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 2001 Feb; 37(2):270-4. PubMed ID: 11230284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What can angiotensin antagonists do that converting-enzyme inhibition can't: the case of post-angioplastic restenosis.
    Pham D; Laporte S; Pérodin J; Bourgeois R; Escher E
    Can J Physiol Pharmacol; 1996 Jul; 74(7):867-77. PubMed ID: 8946074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that nitric oxide regulates AT1-receptor agonist and antagonist efficacy in rat injured carotid artery.
    Lemay J; Hou Y; deBlois D
    J Cardiovasc Pharmacol; 2000 May; 35(5):693-9. PubMed ID: 10813369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up.
    Wiedermann JG; Marboe C; Amols H; Schwartz A; Weinberger J
    J Am Coll Cardiol; 1995 May; 25(6):1451-6. PubMed ID: 7722148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
    MaassenVanDenBrink A; de Vries R; Saxena PR; Schalekamp MA; Danser AH
    Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
    Furukawa Y; Matsumori A; Hirozane T; Sasayama S
    Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
    Campbell DJ
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder.
    Palmer LS; Lee C; Decker RS; Lang S; Kaplan WE; Firlit CF; Cheng EY
    J Urol; 1997 Sep; 158(3 Pt 2):1100-4. PubMed ID: 9258150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
    Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
    Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
    J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AT1-receptor antagonists for the treatment of chronic heart failure.
    Baan J
    Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
    [No Abstract]   [Full Text] [Related]  

  • 40. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
    Porter AJ; Pillidge K; Grabowska EM; Stanford SC
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.